Development of the ^99mTc-Labelled SST₂ Antagonist TECANT-1 for a First-in-Man Multicentre Clinical Study

• Main Authors: Doroteja Novak (Author), Barbara Janota (Author), Anton Amadeus Hörmann (Author), Agnieszka Sawicka (Author), Marko Kroselj (Author), Alicja Hubalewska-Dydejczyk (Author), Melpomeni Fani (Author), Renata Mikolajczak (Author), Petra Kolenc (Author), Clemens Decristoforo (Author), Piotr Garnuszek (Author)
• Format: Book
• Published: MDPI AG, 2023-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Broad availability and cost-effectiveness of ⁹⁹Mo/^99mTc generators worldwide support the use, and thus the development, of novel ^99mTc-labelled radiopharmaceuticals. In recent years, preclinical and clinical developments for neuroe...